June 30, 2023

Omar Veiseh:
Yesterday, Eli Lilly announced a definitive agreement to acquire Sigilon Therapeutics, a biopharmaceutical company that seeks to develop functional cures for patients with a broad range of acute and chronic diseases.  Sigilon Therapeutics was co-founded by Omar Veiseh, Associate Professor of Bioengineering and CPRIT Scholar in Cancer Research at Rice.  Read more.

June 29, 2023

Ion Innovation on Tap Lecture Series (Thanks, Michelle Smith '79!):
Next up in the Ion Innovation on Tap lecture series is Rice Engineering Associate Dean of Research and Innovation Marcia O’Malley today at 4 pm.  Read more.

Bryan Washington: